Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient’s Body Mass Index

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis

(2017) Xiaoping Zhao et al.   Scientific Reports

Comparison Between the Effects of Intravenous Morphine, Tramadol, and Ketorolac on Stress and Immune Responses in Patients Undergoing Modified Radical Mastectomy

(2016) Mohamed A.-E.-M. Bakr et al.   CLINICAL JOURNAL OF PAIN

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Body Fatness and Cancer — Viewpoint of the IARC Working Group

(2016) Béatrice Lauby-Secretan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications

(2016) Valeria Simone et al.   ONCOLOGIST

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression

(2016) Ryan Kolb et al.   Nature Communications

Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis

(2015) María de Pedro et al.   BREAST CANCER RESEARCH AND TREATMENT

A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients

(2015) Y. Guo et al.   CLINICAL CANCER RESEARCH

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis

(2015) Y. Guo et al.   MOLECULAR CANCER THERAPEUTICS

Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women

(2015) Sumie Kato et al.   Oncotarget

Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32

(2015) P. J. Goodwin et al.   JNCI-Journal of the National Cancer Institute

Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases

(2015) Tudor I. Oprea et al.   PLoS One

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

(2014) P. Forget et al.   BRITISH JOURNAL OF ANAESTHESIA

R-ketorolac as a GTPase inhibitor: Phase 0 intraperitoneal pharmacokinetic and biologic activity in ovarian cancer patients

(2014) C. Muller et al.   GYNECOLOGIC ONCOLOGY

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery

(2013) Patrice Forget et al.   ANNALS OF SURGICAL ONCOLOGY

Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice

(2011) Jian-Wei Gu et al.   CANCER BIOLOGY & THERAPY

The Role of the Perioperative Period in Recurrence After Cancer Surgery

(2010) Antje Gottschalk et al.   ANESTHESIA AND ANALGESIA

Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

(2010) Patrice Forget et al.   ANESTHESIA AND ANALGESIA

Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways

(2008) Tamara Jaffe et al.   INTERNATIONAL JOURNAL OF CANCER

Mammalian Rho GTPases: new insights into their functions from in vivo studies

(2008) Sarah J. Heasman et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY